Okupe Oluyemi sold $2.2M of HIMS
Okupe Oluyemi (Chief Financial Officer) sold 64,771 shares of Hims & Hers Health, Inc. (HIMS) at an average of $34.05 ($27.89–$35.09, $2.21M total) across 2 trades over 2026-06-18 to 2026-08-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on insider activity but does not include new operating, financial, or regulatory information about HIMS.
Market read
Traders may monitor insider activity for sentiment, but 10b5-1 structure usually limits actionable signal strength.
What to watch
The filing does not reveal whether the CFO also increased other holdings, and the sale is spread across two dates with a wide price range.
Background
This is an SEC Form 4 insider transaction disclosure for Hims & Hers Health, Inc.
Ticker impact
HIMS CFO Okupe Oluyemi sold about 64,771 shares in open-market transactions totaling $2.21M under a 10b5-1 plan.
Likely minimal near-term price impact; any effect would be sentiment-driven rather than fundamental.
Form 4 details an open-market sale by the CFO with a stated 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
No clear sector read-through from a single CFO 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Insider sales can still coincide with private views on valuation or liquidity needs, even when executed under 10b5-1.
Key entities
- issuerHims & Hers Health, Inc.
Company whose CFO executed open-market sales disclosed on Form 4.
- insiderOkupe Oluyemi
Chief Financial Officer who sold shares totaling about $2.21M under a 10b5-1 plan.
